We further analyzed the expression levels of ACSL4 and GPX4 in three adrenocortical cancer cell lines NCI-H295R30, CU-ACC1 and CU-ACC231 which were subsequently used for all further experiments. This evidence concerns the gene ACSL4 and adrenal cortex carcinoma.